Rule 8 Alltracel Pharmaceutic
2008年2月25日 - 8:40PM
RNSを含む英国規制内ニュース (英語)
RNS Number:6586O
J & E Davy
25 February 2008
FORM 8.1
IRISH TAKEOVER PANEL
Lodge with the Irish Stock Exchange (Company Announcements Office) (which will
publicise) and
the Panel. Use separate form for each class of securities in which dealings have
been made.
Date of Disclosure: 25th February 2008
DISCLOSURE UNDER RULE 8.1(a), 8.1(b)(I) and 8.3 OF THE IRISH TAKEOVER PANEL ACT
1997, (TAKEOVER) RULES, 1997
Date of Dealing: 22nd February 2008
Dealing in Alltracel Pharmaceuticals
(1) Class of Securities (e.g. ordinary shares) Ordinary Eur 0.125
(2)
Amount bought Amount sold Price per unit
36,402 GBP 0.125
(3) Resultant total of the same class owned or controlled (and
percentage of class)
564,532 (0.395%)
(4) Party making disclosure J&E Davy
(5) EITHER (a) Name of purchaser/vendor J&E Davy
OR (b) If dealing for discretionary client(s), name of fund management
Organisation
N/A
(6) Reason for disclosure
(a) (I) offeror or associate of offeror NO
(II) offeree or associate of offeree YES
Specify which category or categories of associate ((a) to (l)
page 3/4)
If category (l) explain
(b) Rule 8.3 (i.e. disclosure because of ownership or control of
1% or more of the class of relevant securities dealt in) NO
Signed, for and on behalf of the party named in (4) above
___________________________
(Also print name of signatory) Mark Smyth
Telephone and extension number 01-6149063
This announcement has been issued through the Companies Announcement Service of
The Irish Stock Exchange.
This information is provided by RNS
The company news service from the London Stock Exchange
END
ISEEAFASADDPEFE
Alltracel Pharmaceuticals (LSE:AP.)
過去 株価チャート
から 4 2024 まで 5 2024
Alltracel Pharmaceuticals (LSE:AP.)
過去 株価チャート
から 5 2023 まで 5 2024
Real-Time news about Alltracel PH. (ロンドン証券取引所): 0 recent articles
その他のAlltracel Pharm Plcニュース記事